查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1293978

客製化抗體的全球市場：按類型、服務、原產地、研究領域、最終用戶、用途- 預測 2023-2030

Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球客製化抗體市場規模預計將大幅成長，2023年將達到4.0763億美元，複合年成長率為19.90%，到2030年將達到14.9758億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球客製化抗體市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 客製化抗體的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球客製化抗體市場的阻礙因素和影響為何？

3. 在預測期內，全球客製化抗體市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球客製化抗體市場的競爭策略是什麼？

5. 全球客製化抗體市場的技術趨勢和法律規範是什麼？

6.全球客製化抗體市場主要廠商的市佔率為何？

7. 哪些型態和策略性舉措被認為適合進入全球客製化抗體市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性感染疾病的盛行率正在增加。
      • 擴展客製化抗體在研究、診斷和治療領域的應用
      • 研發活動快速增加，個體化治療意識增強
    • 抑制因素
      • 開發客製化抗體需要大量的時間和資金。
    • 機會
      • 政府和私營部門持續對生命科學和領域進行策略性投資
      • 抗體療法的增加和藥物管道的擴展
    • 任務
      • 替代抗體的存在導致市場碎片化
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 客製化抗體市場：依類型

  • 單株抗體
  • 多克隆抗體
  • 重組抗體

第7章 客製化抗體市場：依服務分類

  • 抗體開發
  • 抗體片段化和標記
  • 抗體生產和精製

第8章 客製化抗體市場：依來源分類

  • 老鼠
  • 兔子

第9章 客製化抗體市場：依研究領域

  • 心血管疾病
  • 免疫學
  • 感染疾病
  • 神經生物學
  • 腫瘤學
  • 幹細胞

第10章 客製化抗體市場：依最終用戶分類

  • 學術研究所
  • 受託研究機構
  • 醫院和診所
  • 製藥和生物技術公司

第11章客製化抗體市場：依用途

  • 研究
  • 治療

第12章美洲客製化抗體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太訂製抗體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲客製化抗體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業
    • 併購
    • 合約/合作/夥伴關係
    • 新產品發布和功能增強
    • 獎項/獎勵/擴展

第16章上市公司名單

第17章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-46132FF79AAC

The Global Custom Antibody Market is forecasted to grow significantly, with a projected USD 407.63 million in 2023 at a CAGR of 19.90% and expected to reach a staggering USD 1,497.58 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Custom Antibody Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Custom Antibody Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Monoclonal Antibodies commanded largest market share of 34.46% in 2022, followed by Polyclonal Antibodies.

Based on Service, market is studied across Antibody Development, Antibody Fragmentation & Labeling, and Antibody Production & Purification. The Antibody Development commanded largest market share of 31.34% in 2022, followed by Antibody Production & Purification.

Based on Source, market is studied across Mice and Rabbit. The Rabbit commanded largest market share of 34.56% in 2022, followed by Mice.

Based on Research Area, market is studied across Cardiovascular Diseases, Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem cells. The Oncology commanded largest market share of 21.45% in 2022, followed by Immunology.

Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 47.34% in 2022, followed by Contract Research Organizations.

Based on Application, market is studied across Research and Therapeutics. The Research commanded largest market share of 61.46% in 2022, followed by Therapeutics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.10% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Custom Antibody Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Custom Antibody Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Custom Antibody Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Custom Antibody Market?

4. What is the competitive strategic window for opportunities in the Global Custom Antibody Market?

5. What are the technology trends and regulatory frameworks in the Global Custom Antibody Market?

6. What is the market share of the leading vendors in the Global Custom Antibody Market?

7. What modes and strategic moves are considered suitable for entering the Global Custom Antibody Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Custom Antibody Market, by Type, 2022 vs 2030
  • 4.3. Custom Antibody Market, by Service, 2022 vs 2030
  • 4.4. Custom Antibody Market, by Source, 2022 vs 2030
  • 4.5. Custom Antibody Market, by Research Area, 2022 vs 2030
  • 4.6. Custom Antibody Market, by End Users, 2022 vs 2030
  • 4.7. Custom Antibody Market, by Application, 2022 vs 2030
  • 4.8. Custom Antibody Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic infectious disease across the globe
      • 5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
      • 5.1.1.3. Soaring R&D activities and increasing awareness on personalized therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Requirements of huge time and extensive capital to develop custom antibodies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing strategic investments in life science and biology sector by governments and private sectors
      • 5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative antibodies create fragmentation in the market
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Custom Antibody Market, by Type

  • 6.1. Introduction
  • 6.2. Monoclonal Antibodies
  • 6.3. Polyclonal Antibodies
  • 6.4. Recombinant Antibodies

7. Custom Antibody Market, by Service

  • 7.1. Introduction
  • 7.2. Antibody Development
  • 7.3. Antibody Fragmentation & Labeling
  • 7.4. Antibody Production & Purification

8. Custom Antibody Market, by Source

  • 8.1. Introduction
  • 8.2. Mice
  • 8.3. Rabbit

9. Custom Antibody Market, by Research Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Immunology
  • 9.4. Infectious Diseases
  • 9.5. Neurobiology
  • 9.6. Oncology
  • 9.7. Stem cells

10. Custom Antibody Market, by End Users

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Custom Antibody Market, by Application

  • 11.1. Introduction
  • 11.2. Research
  • 11.3. Therapeutics

12. Americas Custom Antibody Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Custom Antibody Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Custom Antibody Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. FPNV Positioning Matrix
  • 15.2. Market Share Analysis, By Key Player
  • 15.3. Competitive Scenario Analysis, By Key Player
    • 15.3.1. Merger & Acquisition
      • 15.3.1.1. LSBio Acquires Absolute Antibody Ltd.
      • 15.3.1.2. AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline
      • 15.3.1.3. KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder
    • 15.3.2. Agreement, Collaboration, & Partnership
      • 15.3.2.1. Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
      • 15.3.2.2. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
      • 15.3.2.3. AltaBioscience partners with Life Science Group for custom antibody production services
      • 15.3.2.4. Sino Biological and Ainnocence partner to offer next-generation antibody development CRO services
      • 15.3.2.5. Ligand signs merger agreement with Avista Public Acquisition
    • 15.3.3. New Product Launch & Enhancement
      • 15.3.3.1. Absolute Biotech launches to offer worldwide antibody solutions
      • 15.3.3.2. Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates
    • 15.3.4. Award, Recognition, & Expansion
      • 15.3.4.1. Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

16. List of Company Mentioned

17. Appendix

  • 17.1. Discussion Guide
  • 17.2. License & Pricing

1. Abbiotec, Inc.

2. Abcam PLC

3. ABclonal, Inc.

4. Abgenex Pvt. Ltd.

5. Abimate Pharmaceutical (Shanghai) Co., Ltd.

6. Abnova Corporation

7. Acrobiosystems Inc.

8. Agilent Technologies, Inc.

9. Alta Bioscience Limited

10. Bio Basic Inc.

11. Bio-Rad Laboratories, Inc.

12. Bio-Techne Corporation

13. BioChain Incorporated

14. Bioklone Biotech Private Limited

15. BioLegend, Inc. by PerkinElmer, Inc.

16. Biosynth Ltd.

17. Boster Biological Technology

18. BTL Biotechno Labs Private Limited

19. Capralogics, Inc.

20. Cell Signaling Technology, Inc.

21. CiteAb Limited

22. Creative Biolabs

23. Creative Diagnostics

24. CSBio (Shanghai) Ltd.

25. Cusabio Technology LLC

26. Davids Biotechnologie GmbH

27. Elabscience

28. evitria AG

29. GenScript Biotech Corporation

30. Imgenex India Pvt. Ltd.

31. Innovagen AB

32. Inotiv, Inc.

33. Kaneka Eurogentec S.A.

34. Laboratory Corporation of America Holdings

35. Merck KGaA

36. Metabion International AG

37. MyBiosource, Inc.

38. OriGene Technologies, Inc.

39. Oy Medix Biochemica AB

40. Pacific Immunology

41. PhosphoSolutions

42. ProMab Biotechnologies, Inc.

43. ProSci Incorporated

44. ProteoGenix SA

45. RayBiotech Life, Inc.

46. Rockland Immunochemicals, Inc.

47. Sino Biological, Inc.

48. The Antibody Company

49. Thermo Fisher Scientific, Inc.

50. YenZym Antibodies, LLC

LIST OF FIGURES

  • FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
  • FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
  • FIGURE 6. CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 7. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2022 VS 2030 (%)
  • FIGURE 8. CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2022 VS 2030 (%)
  • FIGURE 9. CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 10. CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 11. CUSTOM ANTIBODY MARKET DYNAMICS
  • FIGURE 12. CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 22. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 23. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 9. CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 13. CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 16. CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 23. CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 281. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 282. CUSTOM ANTIBODY MARKET LICENSE & PRICING